Axogen, Inc. (AXGN) by event type
AXGN moves most on analyst upgrades — a median of +0.82% at 30 minutes across 13 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the AXGN overview →
How AXGN reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 190 of 2,717 | 13 | +0.82% | 69% | +1.87% |
| Coverage initiations 1,744 of 2,283 | 17 | -0.27% | 41% | +2.80% |
| Rating reiterations 646 of 3,522 | 53 | +0.14% | 53% | +0.05% |
| Price-target raises 1,747 of 1,790 | 13 | -0.60% | 23% | -1.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how AXGN usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · AXGN overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Bruker Corporation (BRKR) | 395 | -0.10% | 46% |
| Neuronetics, Inc. (STIM) | 395 | -0.21% | 45% |
| Fulgent Genetics, Inc. (FLGT) | 393 | +0.04% | 51% |
| Kazia Therapeutics Limited - American Depositary Shares (KZIA) | 393 | -1.07% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.